For the last few months, we’ve been working in collaboration with the specialist centres, homecare delivery companies, and drug manufacturers GSK to bring you regular updates on supply issues related to Flolan – which is also called epoprostenol.
Following an update on 3rd December 2024, we can now confirm that there are full, safe stock levels at suppliers’ warehouses and homecare companies. This means that all supply restrictions have been lifted so affected centres will be able to prescribe Flolan to patients starting on intravenous epoprostenol again. The normal schedule of providing four-week deliveries to patients will continue.
The PHA UK, along with PH teams from every affected centre, have met regularly with homecare delivery companies and GSK since the ‘pause in supply’ in March to lessen any potential impact for patients.
We continue to hold GSK to account for the supply delays and for the anxiety that these issues have caused within our PH community this year. A meeting will take place with them in early 2025 to build closer working relationships, improve communication, and take steps to ensure this does not happen again.
For the last few months, we’ve been working in collaboration with the specialist centres, homecare delivery companies, and drug manufacturers GSK to bring you regular updates on supply issues related to Flolan – which is also called epoprostenol. Following an update on 3rd December 2024, we can now confirm that there are full, safe stock […]
4 December 2024PH researchers from around the UK gathered on 1st November to share study findings, learn from each other’s work, and look to the future together…
12 November 2024A blog by PHA UK Dr Iain Armstrong
15 October 2024An outpouring of love in support of an 11-year-old with PH has raised thousands for our charity and brought huge comfort to her family.
5 September 2024Talented PHA UK member Jamie Beglin has produced a range of eye-catching motif designs that can be used on any type of clothing or merchandise to help get people talking about PH and to raise money for our charity.
10 August 2024Lots of people are talking about the first-in-class PH drug sotatercept, which has recently been approved for use in America. Here, PHA UK Chair Dr Iain Armstrong explains what happens next - and what will be considered when it comes to making decisions for the UK...
30 July 2024